作者
王彦彦,张艳艳,易全勇
文章摘要
目的:探讨腺苷A2A受体拮抗剂KW-6002对链脲佐菌素(STZ)诱导的糖尿病视网膜病变(DR)的作用及可能机制。方法:采用55mg/kg STZ连续5天腹腔注射建立C57BL/6小鼠糖尿病模型。小鼠随机分为对照组、糖尿病模型组(STZ组)和KW-6002治疗组(DB+KW-6002组)。KW-6002组自确诊糖尿病开始以10μg/g腹腔注射,每周1次,连续4周。采用HE染色观察视网膜病理学改变,免疫荧光染色检测胶质纤维酸性蛋白(GFAP)、小胶质细胞标志物(IBA-1)、细胞间粘附分子-1(ICAM-1)的表达。结果:HE染色显示STZ组视网膜结构出现不同程度异常,神经节细胞层和内外核层细胞排列紊乱、数量减少、变性坏死,KW-6002治疗组病变程度较STZ组减轻。免疫荧光分析显示:STZ组GFAP阳性细胞密度显著升高,提示Müller细胞活化;IBA-1阳性细胞密度增加,小胶质细胞活化明显增多;ICAM-1阳性细胞密度上调,提示血管炎症反应增强。KW-6002治疗显著抑制GFAP(P<0.01)/IBA- 1(P<0.01)、ICAM-1(P<0.01)的过度表达。结论:腺苷A2A受体拮抗剂KW-6002能够通过抑制小胶质细胞活化、减轻视网膜炎症反应,对STZ诱导的早期糖尿病视网膜病变发挥一定的保护作用。
文章关键词
DR;腺苷A2A受体;小胶质细胞
参考文献
[1] Hu A,Schmidt MHH,Heinig N.Microglia in retinal angiogenesis and diabetic retinopathy.Angiogenesis.2024;27(3):311-331.
[2] Llorián-Salvador M,Cabeza-Fernández S,Gomez-Sanchez JA,de la Fuente AG.Glial cell alterations in diabetes-induced neurode- generation.Cell Mol Life Sci.2024;81(1):47.
[3] Liu L,He D,Fang L,Yan X.Association between E469K polymorphism in the ICAM1 gene and the risk of diabetic nephropathy:a meta-analysis.Lipids Health Dis.2018;17(1):293.
[4] Boia R,Elvas F,Madeira MH,Aires ID,Rodrigues-Neves AC,Tralhão P,SzabóEC,Baqi Y,Müller CE,ToméÂR,Cunha RA,Ambrósio AF,Santiago AR.Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage.Cell Death Dis.2017;8(10):e3065.
[5] Yamaguchi M,Nakao S,Arima M,Little K,Singh A,Wada I,Kaizu Y,Zandi S,Garweg JG,Matoba T,Shiraishi W,Yamasaki R,Shibata K,Go Y,Ishibashi T,Uemura A,Stitt AW,Sonoda KH.Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation.Diabetologia.2024;67(10):2329-2345.
[6] Li Z,Xiong Q,Li Q,Tang L.Parthenolide ameliorates diabetic retinopathy by suppressing microglia-induced Müller cell gliosis and inflammation via the NF-κB signalling.Int Immunopharmacol.2025;151:114219.
[7] Russo B,D'Addato G,Salvatore G,Menduni M,Frontoni S,Carbone L,Camaioni A,Klinger FG,De Felici M,Picconi F,La Sala G.Gliotic response and reprogramming potential of human Müller cell line MIO-M1 exposed to high glucose and glucose fluctuations.Int J Mol Sci.2024;25(23):12877.
Full Text:
DOI